TY - JOUR
T1 - Age-Related Changes in the Clinical Picture of Long COVID
AU - the RECOVER Consortium
AU - Fain, Mindy J.
AU - Horne, Benjamin D.
AU - Horwitz, Leora I.
AU - Thaweethai, Tanayott
AU - Greene, Meredith
AU - Hornig, Mady
AU - Orkaby, Ariela R.
AU - Rosen, Clifford
AU - Ritchie, Christine S.
AU - Ashktorab, Hassan
AU - Blachman, Nina
AU - Brim, Hassan
AU - Emerson, Sarah
AU - Erdmann, Nathan
AU - Erlandson, Kristine M.
AU - de Erausquin, Gabriel
AU - Fong, Tamara
AU - Geng, Linda N.
AU - Gordon, Howard S.
AU - Gully, Jacqueline Rutter
AU - Hadlock, Jennifer
AU - Han, Jenny
AU - Huang, Weixing
AU - Jagannathan, Prasanna
AU - Kelly, J. Daniel
AU - Klein, Jonathan D.
AU - Krishnan, Jerry A.
AU - Levitan, Emily B.
AU - McComsey, Grace A.
AU - McDonald, Dylan
AU - Montgomery, Aoyjai P.
AU - O'Brien, Lisa
AU - Ofotokun, Ighovwerha
AU - Patterson, Thomas F.
AU - Peluso, Michael J.
AU - Pemu, Priscilla
AU - Perlowski, Alice
AU - Reiman, Eric M.
AU - Sanon, Martine
AU - Seshadri, Sudha
AU - Shellito, Judd
AU - Sherif, Zaki A.
AU - Shikuma, Cecilia
AU - Singer, Nora G.
AU - Singh, Upinder
AU - Trinity, Joel D.
AU - Wisnivesky, Juan
AU - Witvliet, Margot Gage
AU - Foulkes, Andrea
AU - Nikolich, Janko
N1 - Publisher Copyright:
© 2025 The American Geriatrics Society.
PY - 2025/10
Y1 - 2025/10
N2 - Background: This study evaluated the impact of aging on the frequency and prevalent symptoms of Long COVID, also termed post-acute sequelae of SARS-CoV-2, using a previously developed Long COVID research index (LCRI) of 41 self-reported symptoms in which those with 12 or more points were classified as likely to have Long COVID. Methods: We analyzed community-dwelling participants ≥ 60 years old (2662 with prior infection, 461 controls) compared to participants 18–59 years (7549 infected, 728 controls) in the Researching COVID to Enhance Recovery adult (RECOVER-Adult) cohort ≥ 135 days post-onset. Results: Compared to the Age 18–39 group, the adjusted odds of LCRI ≥ 12 were higher for the Age 40–49 group (odds ratio [OR] = 1.40, 95% confidence intervals [CI] = 1.21–1.61, p < 0.001) and 50–59 group (OR = 1.31, CI = 1.14–1.51, p < 0.001), similar for the Age 60–69 group (OR = 1.09, CI = 0.93–1.27, p = 0.299), and lower for the ≥ 70 group (OR = 0.68, CI = 0.54–0.85, p < 0.001). Participants ≥ 70 years had smaller adjusted differences between infected and uninfected symptom prevalence rates than those aged 18–39 for the following symptoms: hearing loss, fatigue, pain (including joint, back, chest pain and headache), post-exertional malaise, sleep disturbance, hair loss, palpitations, and sexual desire/capacity, making these symptoms less discriminating for Long COVID in older adults than in younger. Symptom clustering, as described in Thaweethai et al. (JAMA 2023) also exhibited age-related shifts: clusters 1 (anosmia and ageusia) and 2 (gastrointestinal, chronic cough and palpitations, without anosmia, ageusia or brain fog) were more likely, and clusters 3 (brain fog, but no loss of smell or taste) and 4 (a mix of symptoms) less likely to be found in older adults (relative risk ratios for clusters 3–4 ranging from 0.10–0.34, p < 0.001 vs. 18–39 year-olds). Conclusions: Within the limits of this observational study, we conclude that in community-dwelling older adults, aging alters the prevalence and pattern of reported Long COVID.
AB - Background: This study evaluated the impact of aging on the frequency and prevalent symptoms of Long COVID, also termed post-acute sequelae of SARS-CoV-2, using a previously developed Long COVID research index (LCRI) of 41 self-reported symptoms in which those with 12 or more points were classified as likely to have Long COVID. Methods: We analyzed community-dwelling participants ≥ 60 years old (2662 with prior infection, 461 controls) compared to participants 18–59 years (7549 infected, 728 controls) in the Researching COVID to Enhance Recovery adult (RECOVER-Adult) cohort ≥ 135 days post-onset. Results: Compared to the Age 18–39 group, the adjusted odds of LCRI ≥ 12 were higher for the Age 40–49 group (odds ratio [OR] = 1.40, 95% confidence intervals [CI] = 1.21–1.61, p < 0.001) and 50–59 group (OR = 1.31, CI = 1.14–1.51, p < 0.001), similar for the Age 60–69 group (OR = 1.09, CI = 0.93–1.27, p = 0.299), and lower for the ≥ 70 group (OR = 0.68, CI = 0.54–0.85, p < 0.001). Participants ≥ 70 years had smaller adjusted differences between infected and uninfected symptom prevalence rates than those aged 18–39 for the following symptoms: hearing loss, fatigue, pain (including joint, back, chest pain and headache), post-exertional malaise, sleep disturbance, hair loss, palpitations, and sexual desire/capacity, making these symptoms less discriminating for Long COVID in older adults than in younger. Symptom clustering, as described in Thaweethai et al. (JAMA 2023) also exhibited age-related shifts: clusters 1 (anosmia and ageusia) and 2 (gastrointestinal, chronic cough and palpitations, without anosmia, ageusia or brain fog) were more likely, and clusters 3 (brain fog, but no loss of smell or taste) and 4 (a mix of symptoms) less likely to be found in older adults (relative risk ratios for clusters 3–4 ranging from 0.10–0.34, p < 0.001 vs. 18–39 year-olds). Conclusions: Within the limits of this observational study, we conclude that in community-dwelling older adults, aging alters the prevalence and pattern of reported Long COVID.
KW - Long COVID
KW - age prevalence
KW - epidemiology
KW - older adults
KW - patient-reported outcomes
UR - https://www.scopus.com/pages/publications/105015501358
UR - https://www.scopus.com/pages/publications/105015501358#tab=citedBy
U2 - 10.1111/jgs.70043
DO - 10.1111/jgs.70043
M3 - Article
C2 - 40888500
AN - SCOPUS:105015501358
SN - 0002-8614
VL - 73
SP - 3123
EP - 3137
JO - Journal of the American Geriatrics Society
JF - Journal of the American Geriatrics Society
IS - 10
ER -